annual operating expenses:
$17.46B+$18.81M(+0.11%)Summary
- As of today (May 29, 2025), TAK annual total operating expenses is $17.46 billion, with the most recent change of +$18.81 million (+0.11%) on March 1, 2025.
- During the last 3 years, TAK annual operating expenses has risen by +$387.24 million (+2.27%).
- TAK annual operating expenses is now -0.92% below its all-time high of $17.62 billion, reached on March 31, 2020.
Performance
TAK Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$4.89B-$21.18M(-0.43%)Summary
- As of today (May 29, 2025), TAK quarterly total operating expenses is $4.89 billion, with the most recent change of -$21.18 million (-0.43%) on March 1, 2025.
- Over the past year, TAK quarterly operating expenses has increased by +$1.04 billion (+27.08%).
- TAK quarterly operating expenses is now -26.10% below its all-time high of $6.62 billion, reached on March 31, 2011.
Performance
TAK quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TAK Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.1% | +27.1% |
| 3 y3 years | +2.3% | +18.1% |
| 5 y5 years | -0.9% | +33.5% |
TAK Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5.8% | -8.8% | +43.1% |
| 5 y | 5-year | -0.9% | +5.8% | -8.8% | +43.1% |
| alltime | all time | -0.9% | +506.1% | -26.1% | +728.2% |
TAK Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $17.46B(+0.1%) | $4.89B(-0.4%) |
| Dec 2024 | - | $4.92B(+43.7%) |
| Sep 2024 | - | $3.42B(-18.6%) |
| Jun 2024 | - | $4.20B(+9.1%) |
| Mar 2024 | $17.44B(+5.7%) | $3.85B(-28.3%) |
| Dec 2023 | - | $5.37B(+3.6%) |
| Sep 2023 | - | $5.18B(+25.0%) |
| Jun 2023 | - | $4.15B(+11.0%) |
| Mar 2023 | $16.50B(-3.3%) | $3.74B(-14.2%) |
| Dec 2022 | - | $4.35B(+1.5%) |
| Sep 2022 | - | $4.29B(+5.0%) |
| Jun 2022 | - | $4.08B(-1.5%) |
| Mar 2022 | $17.07B(+1.3%) | $4.14B(-6.4%) |
| Dec 2021 | - | $4.43B(+3.4%) |
| Sep 2021 | - | $4.28B(+2.0%) |
| Jun 2021 | - | $4.20B(-2.9%) |
| Mar 2021 | $16.85B(-4.4%) | $4.32B(+2.5%) |
| Dec 2020 | - | $4.22B(-8.8%) |
| Sep 2020 | - | $4.63B(+25.6%) |
| Jun 2020 | - | $3.68B(+0.5%) |
| Mar 2020 | $17.62B(+55.8%) | $3.67B(-24.2%) |
| Dec 2019 | - | $4.84B(+8.8%) |
| Sep 2019 | - | $4.45B(-4.6%) |
| Jun 2019 | - | $4.66B(-2.7%) |
| Mar 2019 | $11.30B(+15.2%) | $4.79B(+117.4%) |
| Dec 2018 | - | $2.20B(-0.5%) |
| Sep 2018 | - | $2.22B(+4.9%) |
| Jun 2018 | - | $2.11B(-46.2%) |
| Mar 2018 | $9.82B(-1.3%) | $3.92B(+71.8%) |
| Dec 2017 | - | $2.28B(-6.8%) |
| Sep 2017 | - | $2.45B(+105.7%) |
| Jun 2017 | - | $1.19B(-66.2%) |
| Mar 2017 | $9.94B(+4.5%) | $3.53B(+46.8%) |
| Dec 2016 | - | $2.40B(-7.6%) |
| Sep 2016 | - | $2.60B(+92.8%) |
| Jun 2016 | - | $1.35B(-51.1%) |
| Mar 2016 | $9.51B | $2.76B(+16.8%) |
| Dec 2015 | - | $2.36B(+10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $2.13B(-6.1%) |
| Jun 2015 | - | $2.27B(-57.1%) |
| Mar 2015 | $12.68B(+19.5%) | $5.30B(+127.2%) |
| Dec 2014 | - | $2.33B(-6.1%) |
| Sep 2014 | - | $2.48B(+10.6%) |
| Jun 2014 | - | $2.25B(-28.2%) |
| Mar 2014 | $10.60B(-14.8%) | $3.13B(+20.5%) |
| Dec 2013 | - | $2.59B(+4.7%) |
| Sep 2013 | - | $2.48B(+4.0%) |
| Jun 2013 | - | $2.38B(-32.8%) |
| Mar 2013 | $12.44B(+21.1%) | $3.54B(+20.1%) |
| Dec 2012 | - | $2.95B(+0.9%) |
| Sep 2012 | - | $2.92B(+0.8%) |
| Jun 2012 | - | $2.90B(-9.3%) |
| Mar 2012 | $10.27B(+20.4%) | $3.20B(+9.6%) |
| Dec 2011 | - | $2.92B(-17.3%) |
| Sep 2011 | - | $3.53B(+398.5%) |
| Jun 2011 | - | $707.58M(-89.3%) |
| Mar 2011 | $8.53B(+4.1%) | $6.62B(+731.1%) |
| Dec 2010 | - | $796.76M(+10.3%) |
| Sep 2010 | - | $722.23M(+7.0%) |
| Jun 2010 | - | $674.97M(-88.9%) |
| Mar 2010 | $8.20B(-13.5%) | $6.08B(+640.7%) |
| Dec 2009 | - | $820.31M(+8.4%) |
| Sep 2009 | - | $756.49M(+13.6%) |
| Jun 2009 | - | $665.85M(-89.0%) |
| Mar 2009 | $9.48B(+60.5%) | $6.04B(+921.9%) |
| Dec 2008 | - | $590.92M(-26.6%) |
| Sep 2008 | - | $805.39M |
| Mar 2008 | $5.91B(+21.8%) | - |
| Mar 2007 | $4.85B(+4.0%) | - |
| Mar 2006 | $4.66B(+9.2%) | - |
| Mar 2005 | $4.27B(+8.1%) | - |
| Mar 2004 | $3.95B(+10.6%) | - |
| Mar 2003 | $3.57B(+15.6%) | - |
| Mar 2002 | $3.09B(-3.5%) | - |
| Mar 2001 | $3.20B(+11.2%) | - |
| Mar 2000 | $2.88B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total operating expenses?
- What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total operating expenses?
The current annual operating expenses of TAK is $17.46B
What is the all time high annual operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total operating expenses is $17.62B
What is Takeda Pharmaceutical Company Limited annual operating expenses year-on-year change?
Over the past year, TAK annual total operating expenses has changed by +$18.81M (+0.11%)
What is Takeda Pharmaceutical Company Limited quarterly total operating expenses?
The current quarterly operating expenses of TAK is $4.89B
What is the all time high quarterly operating expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total operating expenses is $6.62B
What is Takeda Pharmaceutical Company Limited quarterly operating expenses year-on-year change?
Over the past year, TAK quarterly total operating expenses has changed by +$1.04B (+27.08%)